Guru Ownership Trend
Guru Analysis for Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $319.24 M.
Top institutional holders include Catherine Wood and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $1.35 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 228.2%. Conversely, Murray Stahl reduced exposure by 4.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Beam Therapeutics Inc. (BEAM)
Major holders include Catherine Wood ($289.14 M), Renaissance Technologies (RenTech) ($12.24 M), Paul Tudor Jones ($1.13 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 12.72 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.35 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited BEAM. The total reported sell value was $7.96 M.
Yes, 0 managers opened new positions in BEAM, and 3 increased their existing holdings. The total reported buy value was $9.31 M.